Ye Q, Bodell W J
Department of Neurological Surgery, University of California, San Francisco 94143-0806, USA.
Carcinogenesis. 1996 Aug;17(8):1747-50. doi: 10.1093/carcin/17.8.1747.
Using rat liver microsomal preparations, we have investigated the activation of the anti-estrogen compound tamoxifen (TAM) and its metabolite 4-hydroxytamoxifen (4-OH-TAM) to form 8-hydroxy-2'-deoxyguanosine (8-OH-dG) in DNA. When reduced nicotinamide adenine dinucleotide phosphate (NADPH) was used as a cofactor in microsomal activation of either TAM or 4-OH-TAM, the levels of 8-OH-dG were 3-fold higher than in microsomes plus cofactor only. In contrast, no significant increase in the level of 8-OH-dG was detected in DNA samples from microsomal activation of either TAM or 4-OH-TAM with cumene hydroperoxide as the cofactor. These results demonstrate that the microsomal activation of TAM and 4-OH-TAM to form 8-OH-dG is dependent upon the cofactor used. The addition of either EDTA or catalase to the activation system significantly decreased the formation of 8-OH-dG by TAM, but not by 4-OH-TAM. The presence of either sodium azide, superoxide dismutase or mannitol inhibited the formation of 8-OH-dG by both TAM and 4-OH-TAM. Taken together these findings indicate that microsomal activation of TAM and 4-OH-TAM with NADPH generates reactive oxygen species which result in the formation of 8-OH-dG. We propose that the formation of 8-OH-dG by TAM and its metabolites may contribute to the observed carcinogenic effects of TAM.
我们使用大鼠肝脏微粒体制剂,研究了抗雌激素化合物他莫昔芬(TAM)及其代谢物4-羟基他莫昔芬(4-OH-TAM)在DNA中激活形成8-羟基-2'-脱氧鸟苷(8-OH-dG)的情况。当在TAM或4-OH-TAM的微粒体激活过程中使用还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)作为辅因子时,8-OH-dG的水平比仅含微粒体和辅因子时高3倍。相比之下,在以氢过氧化异丙苯作为辅因子对TAM或4-OH-TAM进行微粒体激活的DNA样品中,未检测到8-OH-dG水平有显著增加。这些结果表明,TAM和4-OH-TAM微粒体激活形成8-OH-dG取决于所使用的辅因子。向激活系统中添加乙二胺四乙酸(EDTA)或过氧化氢酶可显著降低TAM形成8-OH-dG的量,但对4-OH-TAM无效。叠氮化钠、超氧化物歧化酶或甘露醇的存在均抑制TAM和4-OH-TAM形成8-OH-dG。综合这些发现表明,TAM和4-OH-TAM与NADPH的微粒体激活产生了活性氧,从而导致8-OH-dG的形成。我们认为,TAM及其代谢物形成8-OH-dG可能与TAM所观察到的致癌作用有关。